A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

Clinical trial NCT04080206 · COMPLETED

Trial details

NCT number: NCT04080206
Sponsor: Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Plaque Psoriasis

Start date: 2020-04-07
Primary completion: 2021-01-20
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.